Perennial Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Perennial Investment Advisors's BMY Position: Q1 2026 in Review
Perennial Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 5.4% in Q1 2026, buying an estimated $15.7K and bringing the position to 5,295 shares worth $321K. The position accounts for 0.03% of the portfolio, ranked #376.
Perennial Investment Advisors first reported a position in BMY in Q3 2020 and has held it in 19 quarters since. The position peaked at $381K in Q1 2023. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Perennial Investment Advisors held 5,295 shares of Bristol-Myers Squibb worth $321K as of Q1 2026.
- Perennial Investment Advisors bought 269 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.7K.
- Bristol-Myers Squibb made up 0.03% of Perennial Investment Advisors's portfolio in Q1 2026, its #376 holding.
- Perennial Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 19 quarters since.
- Perennial Investment Advisors's Bristol-Myers Squibb position peaked at $381K in Q1 2023.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.